| Holder | Position | Change | Date | |
|---|---|---|---|---|
| Qube Research & Technologies Limited | 1.4% | 0 | 04-Nov-2025 | View History |
| Citadel Advisors LLC | 0.53% | 0 | 26-Sep-2025 | View History |
| Millennium Capital (DIFC) Limited | 1.03% | 0 | 22-Jul-2025 | View History |
| Holder | Position | Change (%) | Date | |
|---|---|---|---|---|
| Sculptor Capital Management Europe Limited | 0.95% | 28-Apr-2015 | View History | |
| Sculptor Capital Management Europe Limited | 1.08% | 27-Apr-2015 | View History | |
| Sculptor Capital Management Europe Limited | 1.14% | 14-Apr-2015 | View History | |
| Sculptor Capital Management Europe Limited | 0.99% | 26-Mar-2015 | View History | |
| Sculptor Capital Management Europe Limited | 1% | 02-Mar-2015 | View History | |
| Sculptor Capital Management Europe Limited | 0.95% | 12-Feb-2015 | View History | |
| Sculptor Capital Management Europe Limited | 0.89% | 02-Feb-2015 | View History | |
| Sculptor Capital Management Europe Limited | 0.72% | 26-Jan-2015 | View History | |
| Sculptor Capital Management Europe Limited | 0.61% | 05-Jan-2015 | View History | |
| Sculptor Capital Management Europe Limited | 0.54% | 02-Jan-2015 | View History |
Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.
Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.
Indivior share price is listed in London under the ticker INDV.